Sign in
4

Changes in Ownership

MAXCYTE, INC. Filed Acc 0001209191-23-055540

Director sold 10,000 shares at $3.71 ($37,100)

  • Director acquired 10,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Johnston John Joseph Director 2023-11-14 Option exercise 10b5-1 +8,717 $1.64 $14,305 129,300 D: show line 1 in the form
Johnston John Joseph Director 2023-11-14 Option exercise 10b5-1 +1,283 $2.14 $2,748 130,583 D: show line 2 in the form
Johnston John Joseph Director 2023-11-14 Sale 10b5-1 −10,000 $3.71 $37,100 120,583 D: show line 3 in the form
Open-market sales · 10,000 sh · avg $3.71 · $37,100

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Johnston John Joseph Director 2023-11-14 Option exercise · Stock Option (right to buy) 10b5-1 −8,717 0 D: show line 4 in the form
Johnston John Joseph Director 2023-11-14 Option exercise · Stock Option (right to buy) 10b5-1 −1,283 25,617 D: show line 5 in the form
Loading xslF345X05/doc4.xml…